Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. - Wikidata - wikimedia - TriplyDB

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.

http://www.wikidata.org/entity/Q34041000

about

Inhibition of G9a Histone Methyltransferase Converts Bone Marrow Mesenchymal Stem Cells to Cardiac Competent Progenitors Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'Cardiac Regenerative Medicine: The Potential of a New Generation of Stem Cells Stem cells for the treatment of heart failure Electromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction.Translational aspects of cardiac cell therapy.Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.Hurdles to clinical translation of human induced pluripotent stem cells 2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development.Pluripotent stem cell applications for regenerative medicine The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Stem cell death and survival in heart regeneration and repair.Comparative transcriptomic analysis identifies genes differentially expressed in human epicardial progenitors and hiPSC-derived cardiac progenitors.Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Current status of pluripotent stem cells: moving the first therapies to the clinic.Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine Pluripotent stem cells progressing to the clinic.Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions.Fibrin, the preferred scaffold for cell transplantation after myocardial infarction? An old molecule with a new life.Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease.Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.Cellular Therapy for Heart Failure.Id genes are essential for early heart formation Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.Are we closer to cardiac regeneration?Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.Involment of RAS/ERK1/2 signaling and MEF2C in miR-155-3p inhibition-triggered cardiomyocyte differentiation of embryonic stem cell.Human Pluripotent Stem Cell-Derived Cardiac Tissue-like Constructs for Repairing the Infarcted Myocardium.Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects.Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart.Generation of Induced Cardiospheres via Reprogramming of Skin Fibroblasts for Myocardial Regeneration.Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction.Bone Marrow Very Small Embryonic-Like Stem Cells: New Generation of Autologous Cell Therapy Soon Ready for Prime Time?Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction.Is Human-induced Pluripotent Stem Cell the Best Optimal?Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.[Cell therapies for cardiopathies: the shift of paradigms].

P2860

Q22306435-4FAF4AA6-0F7C-4FB8-9DFA-0F852EA108CA Q26765883-48D3F811-BCBB-4C5F-A18F-601D656015DB Q26775715-5C47ADE7-6B78-42C6-BD2D-78435DA1C855 Q28079057-0DF94048-3B7B-4DC9-9676-B63B01B0F387 Q28082047-E2DCAAF9-EE0F-4321-8FF9-068FE07E406D Q33722403-7CA4ED6D-2D4F-4C77-8E06-528F16E43B08 Q35995055-7B4F666A-0983-40A0-A701-F7684C350E57 Q36011869-95426AE5-15BA-4477-B35E-7345CC4EDA7E Q36040255-A1B08D7F-562A-474B-B142-138016B49AE6 Q36067846-1B14D80F-23AA-49B5-A7C3-98A0F7F15025 Q36255019-B8C95631-4F91-4A95-956E-5A898D4DB16A Q36756141-A14C29E2-B6C4-4B4F-AEB2-EC6A8F322FB3 Q37016190-FA17A583-DD7F-4CDA-AFE5-4035C87665DA Q37545373-92AD7190-E11B-475A-BA0B-DAA7A7D034AB Q38440913-802398B2-7A5F-40EF-AABE-804D1E554EEC Q38587566-058A0551-158C-4D97-8ACA-4EB4A6306000 Q38590664-31CB6061-99F1-449B-BF9A-D0AF0A67985C Q38626782-40FABC16-29A1-4D02-B5CB-C96980417B35 Q38657334-01DE1EDD-B444-4C80-9BC3-77AE0BFBB2B5 Q38747535-676C0A31-F312-4903-8897-BD7BF39D38F6 Q38796118-F8B64516-E66A-477E-943F-6177EF7D8F76 Q38802979-DB3DBD1F-CE08-49A8-95FD-CAC0FCF92E35 Q38841567-EAD4BBF2-ED1D-4355-BC86-87DEAD532D6E Q38842308-75026956-E7DB-4C1D-81AC-DC2D26997346 Q38859871-488BA536-5B95-4790-B700-D2069FF8F5F7 Q41590446-0F409405-C464-4943-A3FF-AB6288A8BC52 Q41896979-F5DAE44B-C7AC-494A-855F-379DFF8349F1 Q42370394-F1C468E6-AA00-422C-963D-453EB8977604 Q46374324-FA530A48-559D-4094-9DF3-0B16299E3D5F Q47100264-3BEC7787-DEC4-40D9-A44A-F23F3EB8F6BC Q47377047-8ABB7FC1-58C4-41E4-A57A-F70634E6F6FE Q47719713-21ADC9FE-798B-4284-BAE5-294CC5E2CCF5 Q48623367-489BA56B-9862-45B9-B68E-AE7C1707B48E Q48661614-967A35E9-79D0-4049-95F5-9EF159DE5077 Q49341169-FE382B26-F6E4-48D0-AA2C-A7F7E22EFDBA Q50946128-609E9457-FF5C-4F62-8010-FE4D89E8613D Q51019182-FC89BC5E-4C81-4697-9169-89E4E7F83BEB Q52631688-8D125F5E-36F1-4B11-8AD9-30D4B2DB0270 Q52729630-82A844B3-DA99-457B-8179-7623DEF37485 Q53670624-6FD23B2A-8198-4756-B243-67D3848E744C

P2860

Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.

http://www.wikidata.org/entity/Q34041000

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Towards a clinical use of huma ...... s: a translational experience.

@ast

Towards a clinical use of huma ...... s: a translational experience.

@en

Towards a clinical use of huma ...... s: a translational experience.

@nl

type

label

Towards a clinical use of huma ...... s: a translational experience.

@ast

Towards a clinical use of huma ...... s: a translational experience.

@en

Towards a clinical use of huma ...... s: a translational experience.

@nl

prefLabel

Towards a clinical use of huma ...... s: a translational experience.

@ast

Towards a clinical use of huma ...... s: a translational experience.

@en

Towards a clinical use of huma ...... s: a translational experience.

@nl

P1433

Q34041000-C11E645B-95AF-4216-A587-05DC48098F5E

P1476

Q34041000-25A5607B-12BB-43E9-BC0E-7362E0C72D0E

P2093

Q34041000-11AD8185-E345-4EA5-8BB3-71479BE39EAE

Q34041000-468DD9B1-EF46-4102-8459-A50A17896615

Q34041000-48F121C8-C957-4E8D-BB36-23AC86319103

Q34041000-63946DE6-81C7-4650-A368-1D0EC3201294

Q34041000-70EE8802-3FCF-446B-92B1-7AC03F863A4E

Q34041000-8E30F314-5CBD-4081-BE10-479DD6FEC24A

Q34041000-ADFC2A8D-E1F0-4D73-A451-516ABDAA7580

Q34041000-AE5B8109-70E7-4E38-A8A3-681C31A3F45F

Q34041000-CB105293-5379-4A30-8563-A8145B1964BA

Q34041000-EA568CA4-4E9F-47DB-B225-C3A807665909

P2860

Q34041000-033E3792-C923-4D50-96E1-D2E9DA074855

Q34041000-108E4BEB-7A54-48CF-85FB-E3CC74C0B1CC

Q34041000-16566244-17F4-4E6D-A6C5-582EF9E6EE00

Q34041000-1748A7F8-644A-4683-9016-B21814B13E97

Q34041000-18223D0D-3013-48B3-91B5-5C87C6E98AB6

Q34041000-1A4D915C-E224-4106-A01D-F3AC48B31572

Q34041000-1B7F0DE7-38F9-42B7-938E-1B594D5A6B2C

Q34041000-221A7A9F-756F-45C0-A684-A1443CB74B23

Q34041000-26048B55-A6EC-4AA3-9F0B-6B121973014F

Q34041000-271FAA6A-FE15-4C8C-A942-1A22E5F94F8A

P304

Q34041000-2144E4F9-1ECF-4356-A8F2-FAE3A2FA4692

P31

Q34041000-DE60FB25-28B5-4B53-A2BF-D9ADC632883C

P356

Q34041000-111ADBD3-6870-4E0B-A33A-18D9FECC22EA

P433

Q34041000-9075C716-C923-4E79-83BF-835117521DF1

P478

Q34041000-650F3296-356B-4B70-9D1C-7E17AC990495

P50

Q34041000-0B856FC6-FBC3-4584-9BF4-C45946B75721

Q34041000-2D028846-A703-453F-8184-EF774C2327E1

Q34041000-3A938570-490F-4505-8365-0E0116FA51C2

Q34041000-9B48B07D-532B-437D-B085-37555B4DD9C3

Q34041000-A5993DE8-D2DF-4FF4-8A33-C64D16F03B62

Q34041000-B0D92DC4-14D6-4E0A-BE8D-FF01364646C3

Q34041000-F2EF0249-B43F-47B1-ACF8-E1AA7D534459

P577

Q34041000-9FBD68EA-D521-4B44-B075-2F51FAED30B7

P5875

Q34041000-D9362CBD-1222-4693-8017-4D21F28CD048

P698

Q34041000-24C8E037-7FEB-42C9-A89F-5636C621F751

P356

P1433

European Heart Journal

P1476

Towards a clinical use of huma ...... s: a translational experience.

@en

P2093

Alain Bel

http://www.w3.org/2001/XMLSchema#string

Jean-Hugues Trouvin

http://www.w3.org/2001/XMLSchema#string

Jean-Roch Fabreguettes

http://www.w3.org/2001/XMLSchema#string

Julia Pouly

http://www.w3.org/2001/XMLSchema#string

Jérôme Larghero

http://www.w3.org/2001/XMLSchema#string

Marie-Cécile Périer

http://www.w3.org/2001/XMLSchema#string

Michel Desnos

http://www.w3.org/2001/XMLSchema#string

Odile Damour

http://www.w3.org/2001/XMLSchema#string

Patrick Bruneval

http://www.w3.org/2001/XMLSchema#string

Philippe Menasché

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression

Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate

Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating

Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells?

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

P304

743-750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHU192

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Gérard Tachdjian

Valerie Vanneaux

P577

2014-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262422466

http://www.w3.org/2001/XMLSchema#string

P698

24835485

http://www.w3.org/2001/XMLSchema#string